|
|
Current Progress on Clinical Application and Quantitative Methods of Insulin-like Growth Factor-1 |
ZHAO Xu,JIN You-xun,WANG Xian-xia,WU Li-qing,LIU Ya-hui |
Center for Advanced Measurement Science, National Institute of Metrology, Beijing 100029, China |
|
|
Abstract Insulin-like growth factor-1 (IGF-1) is a peptide hormone composed of 70 amino acids. Clinical studies have found that IGF-1 was closely related to endocrine diseases, cardio-cerebrovascular diseases, cancer tumors, diseases related to brain and nervous system, skin diseases, liver diseases and other diseases. IGF-1 was also found to play an important role in research of COVID-19. Therefore, the changes of serum IGF-1 content can be accurately detected as one of the auxiliary diagnostic indicators of related diseases. At present, the clinical detection methods for IGF-1 mainly include immunological analysis methods based on antigen-antibody specific binding and analysis methods based on mass spectrometry. These methods have different detection characteristics and different measurement accuracy. The relevant research progress of IGF-1 is reviewed, the functional role of IGF-1 in clinical detection and application are summarized, and the characteristics and application scenarios of its detection methods are discussed, the suggestions for further improving the detection ability of IGF-1 are also put forward.
|
Received: 21 March 2022
Published: 08 March 2023
|
|
|
|
|
|
Xie Q, Li J N. Research Progress of Insulin-Like Growth Factor-1 Derivatives[J]. Journal of Jianghan University (Natural Science Edition), 2019, 47: 555-562.
|
|
Yu L D, Shen G. The relationship of insulin-like growth factor and cutaneous tumor[J]. Journal of Clinical Dermatology, 2017, 46: 215-217.
|
[13] |
刘晓光, 徐苗苗, 陈佩杰, 等. IGF-1在治疗骨骼肌损伤中的应用潜能及其相关机制[J]. 生命的化学, 2016, 36: 496-502.
|
[22] |
邹晓岚, 叶茸茸, 王洋, 等. 胰岛素样生长因子-1及其受体在肿瘤中的研究进展[J]. 重庆医学, 2018, 47: 2474-2476.
|
[24] |
余立冬, 沈干. 胰岛素样生长因子与皮肤肿瘤[J]. 临床皮肤科杂志, 2017, 46: 215-217.
|
[28] |
吕淑萍, 尚茹茹, 张锦, 等. 胰岛素样生长因子-1对动脉粥样硬化处血管平滑肌细胞的影响[J]. 中华临床医师杂志(电子版), 2016, 10: 3425-3427.
|
[2] |
Salmon W D, Daughaday W H. A hormonally controlled serum factor which stimulates sulfate incorpation by cartilage invitro[J]. Journal of Laboratory and Clinical Medicine, 1957, 49(6): 825-836.
|
[3] |
Rinderknecht E, Humbel R E.
|
[8] |
廖明, 尹琦, 梁江燕, 等. 胰岛素样生长因子结合蛋白相关蛋白1与2型糖尿病胰岛素抵抗的相关性研究[J]. 糖尿病新世界, 2017, 20: 17-19.
|
[10] |
李剑波, 汪承亚, 陈家伟, 等. 实验性糖尿病大鼠胰岛素样生长因子-1基因表达异常与神经电生理及外周神经病变[J]. 中国临床康复, 2004,8(6): 1168-1170.
|
|
Zou X L, Ye R R, Wang Y, et al. Insulin like growth factor-1 and its receptors in cancer[J]. Chongqing Medicine, 2018, 47: 2474-2476.
|
[1] |
Mueller P L, Pritchett C E, Wiechman T N, et al. Antidepressant-like effects of insulin and IGF-1 are mediated by IGF-1 receptors in the brain[J]. Brain Research Bulletin, 2018, 143: 27-35.
|
|
Polypeptides with nonsuppressible insulin-like and cell-growth promoting activities in human serum: isolation, chemical characterization, and some biological properties of forms I and II[J]. Proc Natl Acad Sci U S A, 1976, 73(7): 2365-9.
|
[6] |
Tuncel D, Tolun F I, Toru I. Serum Insulin-Like Growth Factor-1 and Nitric Oxide Levels in Parkinsons Disease[J]. Mediators of Inflammation, 2009, doi:10.1155/2009/132464.
|
[7] |
Yakar S, Isaksson O. Regulation of skeletal growth and mineral acquisition by the GH/IGF-1 axis: Lessons from mouse models[J]. Growth Hormone & Igf Research, 2016, 28: 26-42.
|
|
Liao M, Yin Q, Liang J Y, et al. Correlation Studies of Insulin-like Growth Factor Binding Protein Related Protein 1 and Type 2 Diabetes Insulin Resistance[J]. Diabetes New World, 2017, 20: 17-19.
|
[9] |
Rauskolb S, Dombert B, Sendtner M. Insulin-like growth factor 1 in diabetic neuropathy and amyotrophic lateral sclerosis[J]. Neurobiology of Disease, 2017, 97: 103-113.
|
|
Li J B, Wang C Y, Chen J W, et al. Insulin like growth factor-1 gene expression abnormality and pathologic changes of nervous electrophysiology and peripheral nerves in experimental diabetic rats[J]. Chinese Journal of Clinical Rehabilitation, 2004,8(6): 1168-1170.
|
|
Guo H L, Yang Y, Geng Z P, et al. The change of insulin like growth factor 1 in the patients with diabetic neuropathy[J]. Chinese Journal of Nervous and Mental Diseases, 1999, 25(1): 11-13.
|
|
Liu X G, Xu M M, Chen P J, et al. The prospect and related mechanism of insulin-like growth factor-1 in the treatment of skeletal muscle injury[J]. Chemistry of Life, 2016, 36: 496-502.
|
[15] |
Kordowitzki P, Krajnik K, Skowronska A, et al. Pleiotropic Effects of IGF1 on the Oocyte[J]. Cells, 2022, 11(10): 1-7.
|
[23] |
苏影, 许晶晶, 李宁宁, 等. 胰岛素样生长因子1在肾癌组织中的表达研究进展[J]. 中国医药导报, 2019, 16: 27-29.
|
[29] |
余星, 郑坚奕, 蔡腾飞, 等. 胰岛素样生长因子1在心力衰竭中的研究进展[J]. 中国动脉硬化杂志, 2019, 27: 819-822.
|
[4] |
谢倩, 李佳楠. 胰岛素样生长因子-1衍生物的研究进展[J]. 江汉大学学报(自然科学版), 2019, 47: 555-562.
|
[5] |
Sadaba M C, Martin-Estal I, Puche J E, et al. Insulin-like growth factor 1 (IGF-1) therapy: Mitochondrial dysfunction and diseases[J]. Biochimica Et Biophysica Acta-Molecular Basis of Disease, 2016, 1862(7): 1267-1278.
|
[11] |
郭淮莲, 杨毅, 耿稚萍, 等. 胰岛素样生长因子-1与糖尿病神经病变的关系[J]. 中国神经精神疾病杂志, 1999, 25(1): 11-13.
|
[12] |
Gatti R, De Palo CD E F, Antonelli G, et al. IGF-I/IGFBP system: Metabolism outline and physical exercise[J]. Journal of Endocrinological Investigation, 2012, 35(7): 699-707.
|
[14] |
Aguirre G A, Rodriguez De Ita J, De La Garza R G, et al. Insulin-like growth factor-1 deficiency and metabolic syndrome[J]. Journal of Translational Medicine, 2016, 14(3): 1-23.
|
[17] |
Sato A, Sarentonglaga B, Ogata K, et al. Effects of insulin-like growth factor-1 on the in vitro maturation of canine oocytes[J]. Journal of Reproduction and Development, 2018, 64(1): 83-88.
|
[18] |
Shiomi S N, Komatsu K, Wang J, et al. Regulation of secondary follicle growth by theca cells and insulin-like growth factor 1[J]. Journal of Reproduction and Development, 2015, 61(3): 161-168.
|
[19] |
马俊贤, 张俊伟, 陈健, 等. 血清IGF1、MMP9水平与宫颈癌患者FIGO分期的关联性及动态监测指导意义[J]. 实验与检验医学, 2022, 40(1): 66-68.
|
[20] |
Vella V, Malaguarnera R, Nicolosi M L, et al. Discoidin domain receptor 1 modulates insulin receptor signaling and biological responses in breast cancer cells[J]. Oncotarget, 2017, 8(26): 43248-43270.
|
[25] |
黄炉仁, 曹楚楚, 吴波, 等. 胰岛素样生长因子-1及其受体在子宫内膜癌中的研究进展[J]. 现代妇产科进展, 2016, 25: 472-474.
|
|
Gao Y, Chen C, Wang J, et al. Antigen and Antibody Detection of SARS-CoV-2[J]. Acta Metrologica Sinica, 2020, 41(5): 513-517.
|
[53] |
王宁, 付立业, 隋承光, 等. 胃癌患者血清中IGF-1与CEA、CA125、CA199、CA724水平的相关性分析及在胃癌诊断中的意义[J]. 中国实验诊断学, 2021, 25(2): 194-197.
|
[16] |
Kaya A, Sagirkaya H, Misirlioglu M, et al. Leptin and IGF-I improve bovine embryo quality in vitro[J]. Animal Reproduction, 2017, 14(4): 1151-1160.
|
|
Su Y, Xu J J, Li N N, et al. Progress in the expression of insulin-like growth factor-1 in renal cell carcinoma[J]. China Medical Herald, 2019, 16: 27-29.
|
[26] |
Juul A. Serum levels of insulin-like growth factor I and its binding proteins in health and disease[J]. Growth Hormone & IGF Research, 2003, 13(4): 113-170.
|
|
Yu X, Zheng J Y, Cai T F, et al. Insulin-like growth factor 1 and heart failure[J]. Chinese Journal of Arteriosclerosis, 2019, 27: 819-822.
|
[32] |
Al-Delaimy W K, Von Muhlen D, Barrett-Connor E. Insulinlike Growth Factor-1, Insulinlike Growth Factor Binding Protein-1, and Cognitive Function in Older Men and Women[J]. Journal of the American Geriatrics Society, 2009, 57(8): 1441-1446.
|
[34] |
Tumati S, Burger H, Martens S, et al. Association between Cognition and Serum Insulin-Like Growth Factor-1 in Middle-Aged & Older Men: An 8 Year Follow-Up Study[J]. Plos One, 2016, 11(4): 1-12.
|
|
Kang X P, Long F, Xue Q, et al. Serological indexes and peripheral blood immune index detection in patients with alopecia areata and its correlation with hair loss area[J]. Journal of Hainan Medical University, 2015, 21: 134-136.
|
[38] |
张永卓, 王晶, 傅博强, 等. 2019新型冠状病毒的核酸检测[J]. 计量学报, 2020, 41(4): 393-398.
|
[41] |
Zhao M, Liu Z, Shao F, et al. Communication Pattern Changes Along With Declined IGF1 of Immune Cells in COVID-19 Patients During Disease Progression[J]. Frontiers in Immunology, 2022, 12: 1-14.
|
[45] |
Coppieters G, Judak P, Van Haecke N, et al. A high-throughput assay for the quantification of intact Insulin-like Growth Factor I in human serum using online SPE-LC-HRMS[J]. Clinica Chimica Acta, 2020, 510: 391-399.
|
[46] |
Cao B, Peng Y, Song W, et al. Pediatric Continuous Reference Intervals of Serum Insulin-like Growth Factor 1 Levels in a Healthy Chinese Children Population-Based on PRINCE Study[J]. Endocrine Practice, 2022, 28(7): 696-702.
|
|
Deng Q, Chen Y Q, Wang J J, et al. Changes of Serum IGF-1, IGFBP-3, 25(OH)D and Cortisol in Children with Idiopathic Short Stature before and after Treatment and Their Correlation with Physical Development and Bone Age[J]. Progress in Modern Biomedicine, 2022, 22(18): 3524-3527.
|
[50] |
Pérez-Muuzuri A, López-Suárez O, Mandiá-Rodríguez N, et al. Validation of an IGF1 Screening Method for Retinopathy of Pre-maturity[J]. Front Pediatr, 2020, 8: 1-7.
|
[62] |
Zubarev R A, Makarov A. Orbitrap Mass Spectrometry[J]. Analytical Chemistry, 2013, 85(11): 5288-5296.
|
|
Ma J X, Zhang J W, Chen J, et al. Association of serum levels of IGF1 and MMP9 with FIGO stage of cervical cancer patients and guidance of dynamic monitoring[J]. Experimental and Laboratory Medicine, 2022, 40(1): 66-68.
|
[21] |
Schock H, Fortner R T, Surcel H M, et al. Early pregnancy IGF-I and placental GH and risk of epithelial ovarian cancer: A nested case-control study[J]. International Journal of Cancer, 2015, 137(2): 439-447.
|
|
Huang L R, Cao C C, Wu B, et al. Insulin like growth factor-1 and its receptors in endometrial cancer[J]. Progress in Obstetrics and Gynecology, 2016, 25: 472-474.
|
[27] |
Von Der Thuesen J H, Borensztajn K S, Moimas S, et al. IGF-1 Has Plaque-Stabilizing Effects in Atherosclerosis by Altering Vascular Smooth Muscle Cell Phenotype[J]. American Journal of Pathology, 2011, 178(2): 924-934.
|
[33] |
Doi T, Shimada H, Makizako H, et al. Association of insulin-like growth factor-1 with mild cognitive impairment and slow gait speed[J]. Neurobiology of Aging, 2015, 36(2): 942-947.
|
[35] |
Perice L, Barzilai N, Verghese J, et al. Lower circulating insulin-like growth factor-I is associated with better cognition in females with exceptional Longevity without compromise to muscle mass and function[J]. Aging-Us, 2016, 8(10): 2414-2424.
|
[40] |
Ye Q, Wang B, Mao J. The pathogenesis and treatment of the ‘Cytokine Storm’ in COVID-19[J]. Journal of Infection, 2020, 80(6): 607-613.
|
[42] |
Ilias I, Diamantopoulos A, Botoula E, et al. Covid-19 and Growth Hormone/Insulin-Like Growth Factor 1: Study in Critically and Non-Critically Ill Patients[J]. Frontiers in Endocrinology, 2021, 12: 1-5.
|
[49] |
Tang J H, Ma L L, Yu T X, et al. Insulin-like growth factor-1 as a prognostic marker in patients with acute ischemic stroke[J]. PLoS One, 2014, 9(6): 1-7.
|
[51] |
谢克俭, 潘芙蓉, 夏玉祥, 等. Graves病患者胰岛素样生长因子-1水平和骨密度相关性研究[J]. 中国免疫学杂志, 2004(6): 433-434.
|
|
Wang N, Fu L Y, Sui C G, et al. The correlation analysis of levels of IGF 1 and CEA,CA125,CA199,CA724 in Gastric cancer patients serum and significance in the diagnosis of gastric cancer[J]. Chinese Journal of Laboratory Diagnosis, 2021, 25(2): 194-197.
|
[55] |
Rezaei B, Majidi N, Rahmani H, et al. Electrochemical impedimetric immunosensor for insulin like growth factor-1 using specific monoclonal antibody-nanogold modified electrode[J]. Biosensors & Bioelectronics, 2011, 26(5): 2130-2134.
|
[75] |
汤尧旭, 杨晓东, 张轩溥. 国家标准物质在不同化学发光免疫分析系统上换算系数的研究[J]. 计量学报, 2021, 42(7): 964-970.
|
|
Lü S P, Shang R R, Zhang J, et al. Effect of insulin-like growth factor-1 on vascular smooth muscle cells in atherosclerosis[J]. Chinese Journal of Clinicians(Electronic Edition), 2016, 10: 3425-3427.
|
[30] |
Netchine I, Azzi S, Le Bouc Y, et al. IGF1 molecular anomalies demonstrate its critical role in fetal, postnatal growth and brain development[J]. Best Practice & Research Clinical Endocrinology & Metabolism, 2011, 25(1): 181-190.
|
[31] |
Ashpole N M, Sanders J E, Hodges E L, et al. Growth hormone, insulin-like growth factor-1 and the aging brain[J]. Experimental Gerontology, 2015, 68: 76-81.
|
[37] |
康小平, 龙飞, 薛芹, 等. 斑秃患者血清学指标及外周血免疫指标检测及其与脱发面积的关系[J]. 海南医学院学报, 2015, 21: 134-136.
|
|
Zhang Y Z, Wang J, Fu B Q, et al. Nucleic Acid Detection of the SARS-CoV-2[J]. Acta Metrologica Sinica, 2020, 41(4): 393-398.
|
[39] |
高原, 陈川, 王晶. 2019新型冠状病毒的抗原抗体检测[J]. 计量学报, 2020, 41(5): 513-517.
|
[44] |
Feizollahi P, Matin S, Roghani S A, et al. Evaluation serum levels of Insulin Growth Factor-1 (IGF-1) and its association with clinical parameters in severe COVID-19[J]. Inflammopharmacology, 2022, 30: 199-205.
|
[47] |
Zhu H J, Xu Y, Gong F Y, et al. Reference ranges for serum insulin-like growth factor I (IGF-I) in healthy Chinese adults[J]. Plos One, 2017, 12(10): 1-15.
|
[48] |
邓茜, 陈雨青, 王娟娟, 等. 特发性矮小症患儿治疗前后血清IGF-1、IGFBP-3、25 (OH) D、皮质醇水平变化及其与体格发育和骨龄的相关性分析[J]. 现代生物医学进展, 2022, 22(18): 3524-3527.
|
[52] |
Waldron J, Raymond W, Ostli-Eilertsen G, et al. Insulin-like growth factor-1 (IGF1) in systemic lupus erythematosus: relation to disease activity, organ damage and immunological findings[J]. Lupus, 2018, 27(6): 963-970.
|
[54] |
方晓. 血清Cry61和IGF1在结直肠癌中的表达及临床诊断价值[J]. 中国肛肠病杂志, 2020, 40(6): 1-3.
|
|
Fang X. Expression of Serum Cry61 and IGF1 in Colorectal Cancer,and Their Clinically Diagnostic Value[J]. Chinese Journal of Coloproctology, 2020, 40(6): 1-3.
|
[56] |
Serafin V, Aguei L, Yanez-Sedeno P, et al. Electrochemical immunosensor for the determination of insulin-like growth factor-1 using electrodes modified with carbon nanotubes-poly(pyrrole propionic acid) hybrids[J]. Biosensors & Bioelectronics, 2014, 52: 98-104.
|
[58] |
Gu Y, Liu L, Guo J, et al. Biomolecular assembly on interdigitated electrode nanosensor for selective detection of insulin-like growth factor-1[J]. Artificial Cells Nanomedicine and Biotechnology, 2021, 49(1): 30-37.
|
[70] |
李佳乐, 武利庆, 金有训, 等. 人血清白蛋白纯品含量的同位素稀释质谱方法研究[J]. 计量学报, 2016, 37(3): 328-332.
|
[36] |
Tao S Q, Xia R S, Li F, et al. Efficacy of 3.6% topical ALA-PDT for the treatment of severe acne vulgaris[J]. European Review for Medical and Pharmacological Sciences, 2016, 20(2): 225-231.
|
[43] |
Hazrati E, Gholami M, Farahani R H, et al. The effect of IGF-1 plasma concentration on COVID-19 severity[J]. Microb Pathog, 2022, 164: 1-4.
|
|
Xie K J, Pan F R, Xia Y X, et al. Study on changes and correlation of insulin-like growth factor-1 and bone mineral density in Graves disease[J]. Chinese Journal of Immunology, 2004(6): 433-434.
|
[59] |
Suzuki S, Morimoto S, Fujishiro M, et al. Inhibition of the insulin-like growth factor system is a potential therapy for rheumatoid arthritis[J]. Autoimmunity, 2015, 48(4): 251-258.
|
[60] |
Small B C, Peterson B C. Establishment of a time-resolved fluoroimmunoassay for measuring plasma insulin-like growth factor I (IGF-I) in fish: effect of fasting on plasma concentrations and tissue mRNA expression of IGF-I and growth hormone (GH) in channel catfish (Ictalurus punctatus)[J]. Domestic Animal Endocrinology, 2005, 28(2): 202-215.
|
[63] |
Krastins B, Prakash A, Sarracino D A, et al. Rapid development of sensitive, high-throughput, quantitative and highly selective mass spectrometric targeted immunoassays for clinically important proteins in human plasma and serum[J]. Clinical Biochemistry, 2013, 46(6): 399-410.
|
[64] |
Niederkofler E E, Phillips D A, Krastins B, et al. Targeted selected reaction monitoring mass spectrometric immunoassay for insulin-like growth factor 1[J]. PLoS One, 2013, 8(11): 1-6.
|
[66] |
Bystrom C E, Sheng S, Clarke N J. Narrow Mass Extraction of Time-of-Flight Data for Quantitative Analysis of Proteins: Determination of Insulin-Like Growth Factor-1[J]. Analytical Chemistry, 2011, 83(23): 9005-9010.
|
[68] |
Bronsema K J, Klont F, Schalk F B, et al. A quantitative LC-MS/MS method for insulin-like growth factor 1 in human plasma[J]. Clinical Chemistry and Laboratory Medicine, 2018, 56(11): 1905-1912.
|
[69] |
Pratt M S, Van Faassen M, Remmelts N, et al. An antibody-free LC-MS/MS method for the quantification of intact insulin-like growth factors 1 and 2 in human plasma[J]. Analytical and Bioanalytical Chemistry, 2021, 413(8): 2035-2044.
|
[71] |
Woolfitt A R, Solano M I, Williams T L, et al. Amino Acid Analysis of Peptides Using Isobaric-Tagged Isotope Dilution LC-MS/MS[J]. Analytical Chemistry, 2009, 81(10): 3979-3985.
|
[57] |
Hong X, Hong X Y, Zhao H M, et al. Improved immunoassay for Insulin-like Growth Factor 1 detection by aminated silica nanoparticle in ELISA[J]. Process Biochemistry, 2020, 91: 282-287.
|
[61] |
Fahrner R L, Lester P M, Blank G S, et al. Real-time control of purified product collection during chromatography of recombinant human insulin-like growth factor-I using an on-line assay[J]. Journal of Chromatography A, 1998, 827(1): 37-43.
|
[67] |
Such-Sanmartin G, Bache N, Callesen A K, et al. Targeted mass spectrometry analysis of the proteins IGF1, IGF2, IBP2, IBP3 and A2GL by blood protein precipitation[J]. Journal of Proteomics, 2015, 113: 29-37.
|
|
Li J L, Wu L Q, Jin Y X, et al. Determination of the Mass Fraction of Pure Human Serum Albumin by HPLC-IDMS[J]. Acta Metrologica Sinica, 2016, 37(3): 328-332.
|
[72] |
Elbert D L, Mawuenyega K G, Scott E A, et al. Stable isotope labeling tandem mass spectrometry (SILT): Integration with peptide identification and extension to data-dependent scans[J]. Journal of Proteome Research, 2008, 7(10): 4546-4556.
|
[73] |
Furlanetto R W, Underwood L E, Vanwyk J J, et al. Estimation of somatomedin-c levels in normals and patients with pituitary disease by radioimmunoassay[J]. Journal of Clinical Investigation, 1977, 60(3): 648-657.
|
|
Tang Y X, Yang X D, Zhang X B. Research on Conversion Factors of the Certified Reference Materials on Different Chemiluminescence Immunity Platforms[J]. Acta Metrologica Sinica, 2021, 42(7): 964-970.
|
[77] |
Ibba A, Corrias F, Guzzetti C, et al. IGF1 for the diagnosis of growth hormone deficiency in children and adolescents: a reappraisal[J]. Endocr Connect, 2020, 9(11): 1095-1102.
|
[65] |
Oran P E, Trenchevska O, Nedelkov D, et al. Parallel Workflow for High-Throughput (>1,000 Samples/Day) Quantitative Analysis of Human Insulin-Like Growth Factor 1 Using Mass Spectrometric Immunoassay[J]. Plos One, 2014, 9(3): 1-8.
|
[74] |
Kucera R, Topolcan O, Pecen L, et al. Reference values of IGF1, IGFBP3 and IGF1/IGFBP3 ratio in adult population in the Czech Republic[J]. Clinica Chimica Acta, 2015, 444: 271-277.
|
[76] |
Brabant G, Von Zur Muhlen A, Wuster C, et al. Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: Results from a multicenter study[J]. Hormone Research, 2003, 60(2): 53-60.
|
|
|
|